XTL Biopharmaceuticals Ltd. (H2K2)
Market Closed
25 May, 20:00
XFRA 
€
1. 99
+0.02
+1.0152%
€
- Market Cap
- P/E Ratio
- Div Yield
493 Volume
0 Eps
€ 1.97
Previous Close Want to track H2K2 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
H2K2 Earnings Reports FAQ
What is the earnings per share (EPS) for H2K2?
The current EPS is 0.
What is the company's earnings growth rate?
XTL Biopharmaceuticals Ltd has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
XTL Biopharmaceuticals Ltd has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for XTL Biopharmaceuticals Ltd are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for H2K2 at this time, as XTL Biopharmaceuticals Ltd has no recent EPS data to calculate it.
